New antibody drug stops aggressive prostate cancer from spreading
A newly developed therapeutic antibody has demonstrated the ability to inhibit the growth and metastasis of aggressive prostate cancer in laboratory models.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Researchers have developed a fully human antibody designed to target and slow the progression of aggressive prostate cancer. Coverage indicates that this new treatment has successfully halted tumor growth and the spread of cancer in lab-based testing environments.
Outlets including Technology Networks, Labroots, TheCable, SciTechDaily, Futura, Medical Daily, and ScienceDaily report on the mechanism of the drug. Additionally, Oncodaily highlights that the NINJA prostate cancer trial has concluded its recruitment phase with a total of 472 participants.
Future developments will focus on the ongoing NINJA clinical trial. Coverage does not yet specify the timeline for trial results or the status of potential regulatory approvals.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 9h ago.
Quick answers
What does the new antibody do?
It targets prostate cancer to halt tumor growth and prevent the disease from spreading.
How many participants are in the NINJA trial?
The NINJA prostate cancer trial has completed recruitment with 472 participants.
Is the drug currently available for patients?
Coverage does not specify the current availability of the drug, noting that it has demonstrated results in lab models.
Coverage (8)
- Therapeutic Antibody Halts Prostate Tumor Growth and Metastasis Technology Networks · 1d ago
- Novel Antibody Effectively Targets Prostate Cancer Labroots · 1d ago
- Scientists develop drug that could slow growth of aggressive prostate cancer TheCable · 1d ago
- Researchers Uncover a Promising New Way To Stop Prostate Cancer From Spreading SciTechDaily · 1d ago
- A new generation of prostate cancer drugs is raising hope—here’s why Futura, le média qui explore le monde · 1d ago
- Researchers Develop a Fully Human Antibody That Halted Aggressive Prostate Cancer Growth and Spread in Lab Models Medical Daily · 1d ago
- Jarad Martin: NINJA Prostate Cancer Trial Completes Recruitment With 472 Participants Oncodaily · 1d ago
- New antibody drug stops aggressive prostate cancer from spreading ScienceDaily · 1d ago
Topics
Related trends
There May Be A New Way To Clear Alzheimer's Proteins From The Brain
Emerging research suggests novel methods for clearing toxic Alzheimer's proteins through copper-based drugs and carbon dioxide inhalation.
Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI has entered into an agreement to acquire cancer test manufacturer Personalis for $1.5 billion, triggering a decline in both companies' share prices.
Vaping found to have new, disturbing effect on health
Recent research reveals that vaping is linked to diminished physical fitness and impaired blood vessel function in young adults.
Scientists discover a protein that protects the brain from Alzheimer’s damage
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
An avocado a day keeps the doctor away: new study
A new study on daily avocado consumption has prompted conflicting reports regarding its actual impact on cardiovascular health.
Leading oncologist reveals 6 habits that could promote longevity and reduce your risk of chronic illness
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.